Market Cap (In USD)
3.63 Billion
Revenue (In USD)
91.43 Million
Net Income (In USD)
-551.73 Million
Avg. Volume
-
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 2.81-2.81
- PE
- -
- EPS
- -
- Beta Value
- -0.097
- ISIN
- LU2458333858
- CUSIP
- L01800116
- CIK
- 1898416
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Robert Wessman
- Employee Count
- -
- Website
- https://www.alvotech.com
- Ipo Date
- 2022-06-16
- Details
- Alvotech Holdings SA, through its subsidiaries, develops and manufactures biosimilars for global markets. The company is based in Iceland.
More Stocks
-
002888
-
TECK-ATeck Resources Limited
TECK-A
-
TECK-BTeck Resources Limited
TECK-B
-
DRTSWAlpha Tau Medical Ltd.
DRTSW
-
CALCOMCalcom Vision Limited
CALCOM
-
002762
-
GRP
-
SULABEN